H. Mayaudon, P.-O. Miloche, et B. Bauduceau, « A new simple method for assessing sudomotor function: Relevance in type 2 diabetes », Diabetes Metab., 36, no 6, p. 450‑454, déc. 2010, https://doi.org/10.1016/j.diabet.2010.05.004.
Gaziano T, et al. Health Aff (Millwood). 2015;34:1538–45. https://doi.org/10.1377/hlthaff.2015.0349.
Herman WH, et al. Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care. 2015;38:1449–55. https://doi.org/10.2337/dc14-2459.
Article PubMed PubMed Central Google Scholar
A. Ramachandran, C. Snehalatha, A. Yamuna, S. Mary, et Z. Ping, « Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians », Diabetes Care, vol. 30, no 10, p. 2548‑2552, oct. 2007, https://doi.org/10.2337/dc07-0150.
C. M. Renders, G. D. Valk, S. J. Griffin, E. H. Wagner, J. ThM. Eijk van, et W. J. J. Assendelft, « Interventions to Improve the Management of Diabetes in Primary Care, Outpatient, and Community Settings », Diabetes Care, vol. 24, no 10, p. 1821‑1833, oct. 2001, https://doi.org/10.2337/diacare.24.10.1821.
A. Vinik, J. Ullal, H. K. Parson, et C. M. Casellini, « Diabetic neuropathies: clinical manifestations and current treatment options », Nat. Clin. Pract. Endocrinol. Metab., vol. 2, no 5, p. 269‑281, mai 2006, https://doi.org/10.1038/ncpendmet0142.
Cunha-Vaz J. Diabetic Retinopathy WORLD SCIENTIFIC. 2010. https://doi.org/10.1142/7720.
Malik RA, et al. Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev. 2011;27(7):678–84. https://doi.org/10.1002/dmrr.1222.
Article CAS PubMed Google Scholar
A. Hovaguimian et C. H. Gibbons, « Diagnosis and treatment of pain in small-fiber neuropathy », Curr. Pain Headache Rep., vol. 15, no 3, p. 193‑200, juin 2011, https://doi.org/10.1007/s11916-011-0181-7.
Novak P. Electrochemical Skin Conductance Correlates with Skin Nerve Fiber Density. Front Aging Neurosci. 2016;8:199. https://doi.org/10.3389/fnagi.2016.00199.
Article PubMed PubMed Central Google Scholar
Devigili G, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912–25. https://doi.org/10.1093/brain/awn093.
Article PubMed PubMed Central Google Scholar
Yang Z, et al. Autonomic test by EZSCAN in the screening for prediabetes and diabetes. PLoS ONE. 2013;8(2):e56480. https://doi.org/10.1371/journal.pone.0056480.
Article CAS PubMed PubMed Central Google Scholar
B. P. Lare, J. Jost, A. Martin, P.-M. Preux, B. Agnon, et J. Magne, « Valeurs normales de la conductance électrochimique cutanée mesurées par le Sudoscan en population africaine », Rev. Neurol. (Paris), vol. 179, p. S103, avr. 2023, https://doi.org/10.1016/j.neurol.2023.01.568.
Gavan DE, et al. SUDOSCAN, an Innovative, Simple and Non-Invasive Medical Device for Assessing Sudomotor Function. Sensors. 2022;22:7571. https://doi.org/10.3390/s22197571.
Article PubMed PubMed Central Google Scholar
Vinik AI, et al. Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. Diabetes Technol Ther. 2016;18(6):391–8. https://doi.org/10.1089/dia.2015.0396.
A. Bernabe-Ortiz, A. Ruiz-Alejos, J. J. Miranda, R. Mathur, P. Perel, et L. Smeeth, « EZSCAN for undiagnosed type 2 diabetes mellitus: A systematic review and meta-analysis », PLOS ONE, vol. 12, no 10, p. e0187297, oct. 2017, https://doi.org/10.1371/journal.pone.0187297.
Tesfaye S, et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. Diabetes Care. 2010;33:2285–93. https://doi.org/10.2337/dc10-1303.
Article PubMed PubMed Central Google Scholar
Mao F, et al. Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients. J Diabetes Investig. 2017;8:363–8. https://doi.org/10.1111/jdi.12575.
Article CAS PubMed Google Scholar
B. Bauduceau et L. Bordier, « SUDOSCAN et EZSCAN : deux applications pour les diabétiques d’une même technique innovante », Médecine Mal. Métaboliques, vol. 7, no 6, p. 548‑552, déc. 2013, https://doi.org/10.1016/S1957-2557(13)70707-7.
T. Carmoi, E. Bouenizabila, K. Chantal, jean-henri Calvet, et B. Bauduceau, « P114 Évaluation de SUDOSCAN pour le dépistage des complications du diabète en Afrique », Diabetes Metab., vol. 41, p. A61, mars 2015, https://doi.org/10.1016/S1262-3636(15)30227-5.
Ramachandran A, et al. A new non-invasive technology to screen for dysglycaemia including diabetes, Diabetes Res. Clin Pract. 2010;88:302–6. https://doi.org/10.1016/j.diabres.2010.01.023.
X. Chen, L. Chen, R. Ding, Q. Shi, Y. Zhang, et D. Hu, « A preliminary investigation of EZSCANTM screening for impaired glucose tolerance and diabetes in a patient population », Exp. Ther. Med., vol. 9, no 5, p. 1688‑1694, mai 2015, https://doi.org/10.3892/etm.2015.2358.
Chen P, et al. Risk Factors and Management of Gestational Diabetes, Cell Biochem. Biophys. 2015;71:689–94. https://doi.org/10.1007/s12013-014-0248-2.
C.-S. Sheng, W.-F. Zeng, Q.-F. Huang, J.-P. Deslypere, Y. Li, et J.-G. Wang, « Accuracy of a Novel Non-Invasive technology based EZSCAN system for the diagnosis of diabetes mellitus in Chinese », Diabetol. Metab. Syndr., vol. 3, no 1, Art. no 1, déc. 2011, https://doi.org/10.1186/1758-5996-3-36.
S. Hernandez Oe, « EZSCAN as a Screening Tool for Prediabetes and Diabetes in a Large Mexican Population », J. Diabetes Metab., vol. 06, no 03, 2015, https://doi.org/10.4172/2155-6156.1000505.
Tuomilehto J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50. https://doi.org/10.1056/NEJM200105033441801.
Comments (0)